journal article·2024-03

Theoretical explore of bridge and donor engineering for novel naphthalimide based photosensitizers for two-photo photodynamic therapy

Wei-Bo Cui, Xue Wei, Feng-Yi Sun, Lu-Yi Zou, Jing-Fu Guo, Xue-Li Hao, Hui Li, Ai-Min Ren, Song Wang

Dyes and Pigments· Volume 222
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Nonlinear Optical Materials Studies · Porphyrin and Phthalocyanine Chemistry · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (61)

Show source-provided references
1. In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers10.1038/nm.2933 ↗
2. A porphyrin-based metallacage for enhanced photodynamic therapy10.1039/D1NR08293K ↗
3. Cancer-cell-activated in situ synthesis of mitochondria-targeting AIE photosensitizer for precise photodynamic therapy10.1002/anie.202017350 ↗
4. Photodynamic therapy: oncologic horizons10.2217/fon.13.176 ↗
5. Photodynamic therapy in dermatology: past, present, and future
6. Nanotechnology-based photodynamic therapy: concepts, advances, and perspectives10.1615/CritRevTherDrugCarrierSyst.2015011645 ↗
7. Overcoming the Achilles' heel of photodynamic therapy10.1039/C6CS00616G ↗
8. Precise two-photon photodynamic therapy using an efficient photosensitizer with aggregation-induced emission characteristics10.1002/adma.201701076 ↗
9. Superoxide radical photogenerator with amplification effect: surmounting the achilles' heels of photodynamic oncotherapy10.1021/jacs.8b13141 ↗
10. Two-photon excitation nanoparticles for photodynamic therapy10.1039/C6CS00442C ↗
11. Molecular photosensitisers for two-photon photodynamic therapy10.1039/C7CC06133A ↗
12. Mannose-functionalized mesoporous silica nanoparticles for efficient two-photon photodynamic therapy of solid tumors10.1002/anie.201104765 ↗
13. Two-photon absorption and the design of two-photon dyes10.1002/anie.200805257 ↗
14. Hao, X. L.; Guo, J. F.; Ren, A. M.; Zhou, L., Persistent and efficient multimodal imaging for tyrosinase based on two-photon excited fluorescent and room-temperature phosphorescent probes. J Phys Chem A, 10.
15. Theoretical investigation of Ru(II) complexes with long lifetime and a large two-photon absorption cross-section in photodynamic therapy10.1021/acs.jmedchem.3c00047 ↗
16. Photosensitizers with aggregation-induced emission: materials and biomedical applications10.1002/adma.201801350 ↗
17. Superoxide radical photogenerator with amplification effect: surmounting the Achilles' heels of photodynamic oncotherapy10.1021/jacs.8b13141 ↗
18. Advanced photosensitizer activation strategies for smarter photodynamic therapy beacons10.1002/anie.201805246 ↗
19. An acceptor-shielding strategy of photosensitizers for enhancing the generation efficiency of type I reactive oxygen species and the related photodynamic immunotherapy10.1039/D2NR02273G ↗
20. Acceptor planarization and donor rotation: a facile strategy for realizing synergistic cancer phototherapy via type I PDT and PTT10.1021/acsnano.1c10019 ↗
21. Tuning organelle specificity and photodynamic therapy efficiency by molecular function design10.1021/acsnano.9b04430 ↗
22. Cationization to boost both type I and type II ROS generation for photodynamic therapy10.1016/j.biomaterials.2021.121255 ↗
23. Theoretical exploration of type I/type II dual photoreactivity of promising Ru(II) dyads for PDT approach10.1021/acs.inorgchem.6b01782 ↗
24. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm10.1038/ni.1937 ↗
25. Responsive exosome nano-bioconjugates for synergistic cancer therapy10.1002/anie.201912524 ↗
26. Assessment of water-soluble π-extended squaraines as one-and two-photon singlet oxygen photosensitizers: design, synthesis, and characterization10.1021/ja075933a ↗
27. Molecular design of highly efficient heavy-atom-free triplet BODIPY derivatives for photodynamic therapy and bioimaging10.1002/anie.202002843 ↗
28. Exploitation of long-lived (IL)-I-3 excited states for metal-organic photodynamic therapy: verification in a metastatic melanoma model10.1021/ja408426z ↗
29. Recent progress in heavy atom-free organic compounds showing unexpected intersystem crossing (ISC) ability10.1039/C8OB00421H ↗
30. Halogen-free photosensitizers based on meso-enamine-BODIPYs for bioimaging and photodynamic therapy10.1039/D2TB01515C ↗
31. Control and selectivity of photosensitized singlet oxygen production: challenges in complex biological systems10.1002/cbic.200600454 ↗
32. Activatable photosensitizers: agents for selective photodynamic therapy
33. Triplet photosensitizers: from molecular design to applications10.1039/c3cs35531d ↗
34. The origin of efficient triplet state population in sulfur-substituted nucleobases10.1038/ncomms13077 ↗
35. An emerging molecular design approach to heavy-atom-free photosensitizers for enhanced photodynamic therapy under hypoxia10.1021/jacs.9b09220 ↗
36. Efficient intersystem crossing in heavy-atom-free perylenebisimide derivatives10.1021/acs.jpcc.6b01584 ↗
37. Molecular design of highly efficient heavy-atom-free NpImidazole derivatives for two-photon photodynamic therapy and ClO- detection10.1021/acs.jcim.3c00819 ↗
38. Molecular design toward heavy-atom-free photosensitizers based on the C=S bond and their dual functions in hypoxia photodynamic cancer therapy and ClO- detection10.1021/acsami.0c22174 ↗
39. Theoretical study of a two-photon fluorescent probe based on nile red derivatives with controllable fluorescence wavelength and water solubility10.1021/acs.jcim.1c00635 ↗
40. Highly efficient photosensitizers with aggregation-induced emission characteristics obtained through precise molecular design10.1039/C7CC04864E ↗
41. Molecular design of highly efficient heavy-atom-free triplet BODIPY derivatives for photodynamic therapy and bioimaging10.1002/anie.202002843 ↗
42. Band gap tunable, donor-acceptor-donor charge-transfer heteroquinoid-based chromophores: near infrared photoluminescence and electroluminescence10.1021/cm801911n ↗
43. Simple and efficient near-infrared organic chromophores for light-emitting diodes with single electroluminescent emission above 1000 nm10.1002/adma.200801918 ↗
44. Frisch · 2016
45. The Dalton quantum chemistry program system10.1002/wcms.1172 ↗
46. MOlecular MAterials Property Prediction Package (MOMAP) 1.0: a software package for predicting the luminescent properties and mobility of organic functional materials10.1080/00268976.2017.1402966 ↗
47. Evaluation of spin-orbit couplings with linear-response time-dependent density functional methods10.1021/acs.jctc.6b00915 ↗
48. Polarizable continuum model
49. An emerging molecular design approach to heavy-atom-free photosensitizers for enhanced photodynamic therapy under hypoxia10.1021/jacs.9b09220 ↗
50. Triplet harvesting using two-photon absorption in substituted naphthalimides for their application as heavy-atom-free photosensitizers10.1021/acs.jpcc.0c01290 ↗
51. Multiwfn: a multifunctional wavefunction analyzer10.1002/jcc.22885 ↗
52. VMD: visual molecular dynamics
53. Solvent induced channel interference in the two-photon absorption process-a theoretical study with a generalized few-state-model in three dimensions10.1039/C1CP22849H ↗
54. Excited state symmetry assignment through polarized two-photon absorption studies of fluids10.1063/1.1676494 ↗
55. Benchmarking two-photon absorption cross sections: performance of CC2 and CAM-B3LYP10.1039/C5CP03241E ↗
56. Visualizing the contributions of virtual states to two-photon absorption cross sections by natural transition orbitals of response transition density matrices10.1021/acs.jpclett.7b01422 ↗
57. Solvent induced channel interference in the two-photon absorption process-a theoretical study with a generalized few-state-model in three dimensions10.1039/C1CP22849H ↗
58. Photophysical properties of porphyrinoid sensitizers non-covalently bound to host molecules; models for photodynamic therapy10.1016/j.ccr.2004.02.004 ↗
59. Photodynamic therapy (PDT) for malignant brain tumors-where do we stand?10.1016/j.pdpdt.2015.04.009 ↗
60. Photophysical origin of the reduced photodynamic therapy activity of temocene compared to Foscan (R): insights from theory10.1039/c3cp52698d ↗
61. Triplet state. Its radiative and nonradiative properties10.1021/ar50001a002 ↗